Research and Development

The Research and Development team at Raqia Therapeutics is dedicated to innovating and advancing chimeric antigen receptor (CAR) technologies for cancer immunotherapy. This skilled team collaborates on designing and optimizing therapeutic candidates, conducting preclinical studies, and ensuring scientific rigor in all development phases to bring transformative therapies from the lab to patients in need.